Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2015-002958-12Phase 4Active
Phase 4, single-arm trial of bupivacaine in None, sponsored by Reinier de Graaf Hospital. Primary endpoint: Primary endpoint: Motor and sensory recovery at 119 minutes. Started Jul 2015; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2015-002958-12.